What is Profhilo?
Profhilo is the first stabilized hyaluronic acid that is obtained without the use of the chemical cross-linking agent BDDE (Butanediol Diglycidyl Ether) in the cross-linking chemical bonding process (BDDE free). It adheres to the standards of the U.S. Food and Drug Administration (FDA) with BDDE content less than 2 ppm.
Profhilo significantly enhances the quality and treatment of skin tissue, especially in challenging areas. It serves as a complementary treatment in aesthetic procedures and skincare, offering notable improvements. For example, this product has excellent compatibility with fat tissue for injection in various areas.
It is considered a safe, effective, and truly remarkable advancement in the medical field for combating the aging process. Profhilo stands out as a product that brings significant innovation to the realm of anti-aging medicine.
Profhilo Awards
IBSA has used its experience and expertise in the pharmaceutical field to branch out and develop medical devices for dermatology
based on hyaluronic acid – thus creating a dedicated dermoaesthetic brand: IBSA Derma. IBSA Derma distinguishes itself in this vast market because it controls the entire product lifecycle, from the biofermentation production
of the raw material to the ready-to-use final product in pre-filled syringes.
Stabilized Hybrid Cooperative Complexes (HCC) of high and low molecular weight Ultrapure Hyaluronic Acid in high concentration, produced with a unique and innovative thermal production process patented by IBSA, the NAHYCO® Technology.
Production Process
Step one:
Beginning with a simple mix: ۳۲ mg of hyaluronic acid high molecular weight (۱۱ ۰۰-۱۴۰۰ kDa) ۳۲ mg of hyaluronic acid low molecular weight (۸۰-۱ ۰۰ kDa)
Step two:
Thermal stabilization process The simple mix is heated and cooled according to IBSA’s patented thermal production process (no chemical cross-linking agents used)
Step tree:
High HA concentration (64m 12ml) Highly manageable4 Extensive spreadability5 Low viscosity4 No BDDE or other chemical agents3 Low inflammatory response4 Thermally stabilized natural HA with a duration comparable to a low cross-linked gel5
THE BAP TECHNIQUE
These 5 points identify the 5 anatomically receptive areas of the face with an absence of large vessels and nerve branches, therefore, minimizing the risks while maximizing the diffusion of the product
in the malar and submalar areas.
۱ .ZYGOMATIC PROTRUSION
at least 2 cm away from the external corner of the eye
۲ .NASAL BASE
- draw a line connecting the nostril and tragus
- draw a perpendicular line starting from the pupil
- locate the injection point at the intersection of the 2 lines
۳ .TRAGUS
۱ cm anterior to the bottom of the tragus
۴.CHIN
- draw a vertical line in the center of the chin
- draw a perpendicular line one third from the top of the vertical line
- from the point of intersection move 1 .5 cm towards the oral commissures
۵ .MANDIBULAR ANGLE
۱ cm above the mandibular angle
Before / After
